Biocon Launches Haselmeier's Insulin Pen in India
Haselmeier recently announced that Biocon, one of Asia’s premier biotechnology companies, has launched INSUPen in
The INSUPen is a reusable insulin pen based on Haselmeier’s popular i-pen technology. It is designed to be easy to use for the patient and provide accurate and reliable dosing. It is available in three attractive colors and is currently custom designed for use with both Basalog and Insugen, thus maximizing patient convenience.
“The INSUPen provides diabetic patients an attractive pen with user-friendly features at an affordable cost. Haselmeier is proud to work with Biocon, a premier biotechnology company, on this important program to develop and supply INSUPen, and we look forward to a long and successful partnership,” said Volker Wirth, Director Business Development & Marketing at Haselmeier.
“I am confident that INSUPen will be a delight for patients and a value enhancer for all Stakeholders,” added Rakesh Bamzai, President, Marketing at Biocon.
Haselmeier is a leading designer and manufacturer of pen and auto-injection systems. The company’s devices feature unique function, design, and technology and are marketed by leading pharmaceutical and biotechnology companies around the world.
Established in 1978, Biocon Limited is
Total Page Views: 2578
